about
Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculiExtracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculiExtra-corporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculiExtra-corporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculiThe elementome of calcium-based urinary stones and its role in urolithiasisNutritional Management of Kidney Stones (Nephrolithiasis)New insights into the pathogenesis of renal calculiNet intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretionMolecular recognition at the protein-hydroxyapatite interface.Nephrolithiasis: how it happens and what to do about it.Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease.Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.A case of a lower pole renal calculus managed with percutaneous nephrolithotomy.Heritability of urinary traits that contribute to nephrolithiasis.Are stone analysis results different with repeated sampling?New insights into causes and treatments of kidney stones.Role of 1,25-dihydroxy vitamin D3 and parathyroid hormone in urinary calcium excretion in calcium stone formers.The increasing pediatric stone disease problemBilateral stones as a cause of acute renal failure in the emergency department.PTH modulation of NCC activity regulates TRPV5 Ca2+ reabsorption.How the overlapping timescales for peptide binding and terrace exposure lead to non-linear step dynamics during growth of calcium oxalate monohydrateRisk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.In vitro Evaluation of Terminalia arjuna on Calcium Phosphate and Calcium Oxalate Crystallization.Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null miceFish oil supplementation and urinary oxalate excretion in normal subjects on a low-oxalate diet.Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosisRandall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using (18)F-NaF.Which anthropometric measurements including visceral fat, subcutaneous fat, body mass index, and waist circumference could predict the urinary stone composition most?A review of the heritability of idiopathic nephrolithiasis.ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis.A (13)C{(31)P} REDOR NMR investigation of the role of glutamic acid residues in statherin- hydroxyapatite recognitionAltered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers.Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic.Modeling hypercalciuria in the genetic hypercalciuric stone-forming ratEffect of Lagenaria siceraria fruit powder on sodium oxalate induced urolithiasis in Wistar rats.Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.Effect of Demographics on Excretion of Key Urinary Factors Related to Kidney Stone RiskMetabolic syndrome and the risk of calcium stones.Type 2 diabetes mellitus and renal stones
P2860
Q24197890-5B95F399-55C8-43D7-B4AC-CC54A301DF09Q24234612-B6F0C797-8AB8-43E7-8D82-9FADA84B21BDQ24244194-90DB2521-D12B-4665-B21C-6F8A4B5946C2Q24246366-B7A7A722-4C14-4B5E-85CC-2FC98F4DD1E9Q26786250-F8BE63C5-10D7-44B8-BCF5-69A19B7854F8Q26801209-8ABB6DF9-0868-4720-B155-ED2BE5CAC684Q27026371-3AA8D3D3-D55D-4E10-99C2-2385E618E6EAQ28593685-C6ABF658-5E8E-477A-B722-7F63623FEBD7Q30336152-8040968F-F44E-4A35-A68B-53B71004E934Q30469794-5FE737A7-9E2C-4528-B3EA-5B83D6B244A0Q31892282-7E6C0B24-A14F-437A-9E18-214690826212Q33227810-05D299D9-4FF1-467F-BEE8-8D647F6A9B80Q33330257-004EA357-F06A-4E81-AD90-D4804EDD456EQ33571796-A3C7C4A7-CF38-46F5-ADE1-EA39DD8AE25BQ33690462-55E39325-93F1-4B5D-8CEA-C65623C387B8Q33875556-DAF0E5FD-35B2-4532-A720-3887B9DF4A71Q33941642-4C9E448F-57C9-4395-972A-A920D9EC0D9DQ33971034-5CC79C02-7DF8-4C03-9022-80CF6CFA7C2BQ34032311-4189CC21-7128-4A0A-813E-53F8AC5FB844Q34045482-52867452-6E3E-407D-9782-2E65DEC1D984Q34108287-E75816DE-4DA7-45E6-A040-2B8E999E2C5CQ34148403-00441871-F216-4801-82F6-27001713F4C6Q34411835-9C66FE4F-7DFD-4659-9969-E4515D4B407AQ34559127-A71FAC18-D5E7-4F93-9178-8C113D82DDF1Q34569333-0190E647-B843-439D-9F50-42839B56E74AQ34695462-73E740BB-2C51-4025-9444-762054575A06Q34834615-8319255E-BE3A-4E49-B407-213BC00E7953Q35058679-4E084B2E-F1A5-4B0C-B70F-198C0A90F9E9Q35238045-1DFE5ADA-9F68-41DA-B301-78C5AEE34F4BQ35587862-24F69862-DA57-481C-B127-24F69FDD5A7BQ35588351-2B062ED1-9DCF-4FDB-B45D-0620E1DFBD49Q35635801-D7415ACE-797F-476D-B00B-6DEC688915DBQ35762545-E8A56351-F8F9-4F10-87DE-9914ECE6531CQ35788301-09F2BD43-548A-4D46-94AF-EDA50E38BF5EQ35830544-028F03BA-4F96-4EA1-894E-68D9FBFD2204Q36021245-73FCA32B-BE58-4DF8-B4C7-3F0398929E59Q36063298-00D54028-05DE-42B4-96AC-0A603750B2C6Q36119367-85A58901-18B9-4D11-AC0D-356D57E3A46DQ36129839-554BC012-8CBC-4F50-A47B-F77A0D662D90Q36196901-EE69893B-4EE4-4CEA-A9F0-035A10F93C04
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The pathogenesis and treatment of kidney stones.
@ast
The pathogenesis and treatment of kidney stones.
@en
type
label
The pathogenesis and treatment of kidney stones.
@ast
The pathogenesis and treatment of kidney stones.
@en
prefLabel
The pathogenesis and treatment of kidney stones.
@ast
The pathogenesis and treatment of kidney stones.
@en
P2093
P1476
The pathogenesis and treatment of kidney stones.
@en
P2093
P304
P356
10.1056/NEJM199210153271607
P407
P577
1992-10-01T00:00:00Z